Health New Data from PROMMIS Study Highlights the Power of SKY92 in Identifying High-Risk Multiple Myeloma Patients December 8, 2024
Health Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) December 8, 2024
Health University of Nebraska Wins the Abbott and Big Ten Conference’s Nationwide ‘We Give Blood Drive’ Competition, Receives $1 Million Grant from Abbott December 8, 2024
Health Researchers Report New Opportunities to Improve Quality of Life for People with Non-Malignant Blood Disorders December 8, 2024
Health Blueprint Medicines’ Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting December 8, 2024
Health Bamboo Technology’s HereHear Virtual AI Therapist Joins Berkeley Skydeck IPP Program December 7, 2024
Health Auditor General Report sheds light on Ford’s reckless waste of public dollars: OPSEU/SEFPO December 7, 2024
Health New Preclinical Data Demonstrate Potential of Capsida’s IV Gene Therapy for STXBP1-DEE to Correct all Disease Manifestations December 7, 2024
Health Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting December 7, 2024